Skip to main content

Table 3 Patient characteristics and procedural's complications

From: Clinical and echocardiographic trends in percutaneous balloon mitral valvuloplasty

Patient characteristics

Complications

(N = 200)

Nocomplications (N = 217)

P-value

Age-adjusted

OR

OR

P-value

Age (Mean ± SD years)

(Median; range)

57.5 ± 10.2

(57; 29–84)

55.0 ± 11.7

(55; 23–88)

.09

1.02

Sex

  

.12

 

.09

 

 Female

166 (49.7)

168 (50.3)

 

1.47

 

1.54

 Male

33 (40.2)

49 (59.8)

 

1.00

 

1.00

    Obesity (BMI > 30)

91 (45.7)

88 (40.7)

.31

1.23

.48

1.15

 Smoking

70 (35.2)

83 (39.2)

.40

0.84

.32

0.82

 Hypertension

100 (50.8)

85 (39.5)

.02

1.58

.07

1.46

 Dyslipidemia

95 (48.5)

94 (43.9)

.36

1.20

.56

1.12

 Diabetes mellitus

55 (28.1)

54 (25.2)

.52

1.16

.82

1.05

 Chronic kidney failure

35 (17.9)

37 (17.5)

.92

1.03

.95

0.98

 Ischemic heart disease

56 (28.9)

66 (30.7)

.69

0.92

.20

0.74

    CABG

8 (4.1)

15 (7.0)

.21

0.57

.20

0.56

 Atrial fibrillation

101 (50.5)

110 (50.9)

.93

0.98

.49

0.87

 Stroke

28 (14.3)

29 (13.6)

.83

1.06

.95

1.02

 Endocarditis

4 (2.1)

6 (2.9)

.61

0.72

.60

0.71

Decade

  

.83

 

.09

 

 1990–1999

73 (44.2)

92 (55.8)

 

1.00

 

1.00

 2000–2009

98 (53.8)

84 (46.2)

.07

1.47

.06

1.51

 2010–2019

29 (41.1)

41 (58.9)

.69

0.89

.75

0.91

Wilkins score, mean ± SD (median, range) 

9.0 ± 1.5

(9; 5–12)

8.8 ± 1.7

(9; 4–13)

.12

1.10

.14

1.10

Wilkins by score  

Rate

 

.37

   

  < 8

35 (42.7)

47 (57.3)

 

1.00

 

1.00

  ≥ 8

37 (42.0)

51 (58.0)

.31

1.29

.29

1.02

  ≥ 9

53 (54.1)

45 (45.9)

.08

1.42

10

1.40

 10

41 (52.6)

37 (47.4)

.54

1.13

.52

1.14

 11+

34 (47.9)

37 (52.1)

.34

1.25

.34

1.25

Calcification of leaflets

  

.72

 

.76

 

 1

41 (47.7)

45 (52.3)

1.00

1.00

 2

89 (47.1)

100 (52.9)

.92

0.98

.89

0.97

 3

56 (51.9)

52 (48.1)

.62

1.16

.66

1.14

 4

14 (41.2)

20 (58.8)

.49

0.75

.50

0.76

Calcification of subvalvular apparatus

  

.80

 

.79

 

 1

33 (45.8)

39 (54.2)

1.00

1.00

 2

93 (47.0)

105 (53.0

.84

1.06

.72

1.11

 3

63 (51.2)

60 (48.8)

.40

1.28

.34

1.33

 4

11 (45.8)

13 (54.2)

>.99

1.00

.86

1.09

Leaflets Mobility

  

.06

 

.11

 

 1

28 (39.4)

43 (60.6)

1.00

1.00

 2

117 (50.6)

114 (49.4)

.14

1.50

.18

1.46

 3

44 (44.4)

56 (55.6)

.62

1.17

.79

1.09

 4

11 (73.3)

4 (26.7)

.03

4.03

.04

3.83

Leaflets Thickening

  

.28

 

0.30

 

 1

27 (39.7)

41 (60.3)

1.00

1.00

 2

85 (47.0)

96 (53.0)

.31

1.34

.29

1.37

 3

81 (53.6)

70 (46.4)

.07

1.71

.07

1.73

 4

7 (41.2)

10 (58.8)

.95

1.04

.78

1.16

 LVEF

58.0 ± 4.7

(60; 45–83)

58.9 ± 4.2

(60; 40–72)

.03

 

0.11

0.96

  1. LVEF left ventricular ejection fraction